Patterns and Levels of Hypoxia in Head and Neck Squamous Cell Carcinomas and Their Relationship to Patient Outcome: In Regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031)

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 5, 2008, Pages 1616-

  Bussink, Johan ^a   van der Kogel, Albert J ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; IMIDAZOLE DERIVATIVE; NICOTINAMIDE; PIMONIDAZOLE;

CELL HYPOXIA; HEAD AND NECK CANCER; HUMAN; LETTER; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

CARBON DIOXIDE; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; HEAD AND NECK NEOPLASMS; HUMANS; NITROIMIDAZOLES; OXYGEN; PROGNOSIS; RADIATION-SENSITIZING AGENTS; TIME FACTORS;

EID: 40949155534     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.052     Document Type: Letter

References (5)

1. Evans S.M., Du K.L., Chalian A.A., et al. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys 69 (2007) 1024-1031
2. Kaanders J.H.A.M., Wijffels K.I.E.M., Marres H.A.M., et al. Pimonidazole binding and tumor vascularity predict for outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
3. Kaanders J.H.A.M., Bussink J., and van der Kogel A.J. ARCON: A novel biology-based approach in radiotherapy. Lancet Oncol 3 (2002) 728-737
4. Ljungkvist A.S.E., Bussink J., Kaanders J.H.A.M., et al. Hypoxic cell turnover in different solid tumors. Int J Radiat Oncol Biol Phys 62 (2005) 1157-1168
5. Rischin D., Hicks R.J., Fisher R., et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24 (2006) 2098-2104